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Inducing immune tolerance to prevent rejection is a
key step toward successful engraftment of stem-
cell-derived tissue in a clinical setting. Using human
pluripotent stem cells to generate thymic epithelial
cells (TECs) capable of supporting T cell develop-
ment represents a promising approach to reach
this goal; however, progress toward generating func-
tional TECs has been limited. Here, we describe a
robust in vitro method to direct differentiation of
human embryonic stem cells (hESCs) into thymic
epithelial progenitors (TEPs) by precise regulation
of TGFb, BMP4, RA, Wnt, Shh, and FGF signaling.
The hESC-derived TEPs further mature into func-
tional TECs that support T cell development upon
transplantation into thymus-deficient mice. Impor-
tantly, the engrafted TEPs produce T cells capable
of in vitro proliferation as well as in vivo immune
responses. Thus, hESC-derived TEP grafts may
have broad applications for enhancing engraftment
in cell-based therapies as well as restoring age-
and stress-related thymic decline.
INTRODUCTION
The use of stem cells to replace lost or damaged tissue repre-
sents one of the most promising applications of stem cell
research. Among the most interesting and clinically relevant
cell types that still haven’t been successfully generated from
human pluripotent stem cells are thymic epithelial cells (TECs).
The thymus plays a crucial role in the immune system by sup-
porting the development of functional T cells. It is also the
main organ involved in establishing immune tolerance through
the elimination of autoreactive T cell subsets (reviewed in Ander-
son et al., 2007). Both of these critical functions are mediated by
TECs, the main component of the thymic stroma. Because the
thymus undergoes profound degeneration with age and when
exposed to stresses such as irradiation and chemotherapy, the
use of stem cells as a potential source of TECs to enhance or
restore thymic function is of great therapeutic interest. Given
the key role of TECs in establishing self-tolerance, differentiationCof a functional thymus from stem cells also has the potential
to enhance engraftment of human-stem-cell-derived tissue
through the induction of graft-specific immune tolerance. How-
ever, directed differentiation of human pluripotent stem cells
into TECs has not been successful to date and remains an
important challenge that needs to be addressed before such
approaches can be developed.
During embryogenesis, the thymus arises from the endoderm
of the third pharyngeal pouch, a specialized pocket of the ante-
rior foregut tube that contains the common primordium for the
prospective thymus and parathyroid glands (Le Douarin and
Jotereau, 1975; Gordon et al., 2004). The outgrowth of thymic
epithelium occurs from the ventral domain of the third pharyn-
geal pouch in response to developmental cues such as FGFs,
BMP4, and Wnt ligands (Balciunaite et al., 2002; Bleul and
Boehm, 2005; Patel et al., 2006). Crosstalk with lymphoid pro-
genitors that colonize the thymus subsequently allows differenti-
ation of common thymic epithelial progenitors (TEPs) into two
populations of mature TECs: cortical TECs (cTECs) and medul-
lary TECs (mTECs) (Rodewald, 2008).
Although previous studies have reported the successful differ-
entiation of human pluripotent stem cells into definitive endo-
derm (DE) and anterior foregut endoderm (AFE) (D’Amour
et al., 2005; Green et al., 2011), they failed to demonstrate sub-
sequent specification to the thymic lineage. Here we show that
in-vitro-directed differentiation of human embryonic stem cells
(hESCs) into TEPs can be achieved through recapitulation of
the embryonic signaling events that guide thymic development
in vivo. We have found that a precise temporal control of the
activities of TGFb, retinoic acid (RA), BMP,Wnt, Sonic Hedgehog
(Shh), and FGF signaling is required to efficiently generate TEPs
in vitro. Importantly, we demonstrate that TEPs derived using
this method mature into functional TECs that support T cell
development upon transplantation into athymic mice.
RESULTS
In-Vitro-Directed Differentiation of hESCs into TEPs
Even though the molecular mechanisms responsible for speci-
fying thymus fate are still uncertain, prior work has identified
the Foxn1 and Hoxa3 transcription factors as early and essential
regulators of thymus specification and differentiation of
TEPs into mature TECs (Manley and Capecchi, 1995; Nehls
et al., 1996). We therefore focused our efforts on developing aell Stem Cell 13, 219–229, August 1, 2013 ª2013 Elsevier Inc. 219
Figure 1. Directed Differentiation of hESCs
into TEPs
(A) Schematic of differentiation protocol and
marker genes for specific stages. ES, embryonic
stem cells; DE, definitive endoderm; AFE, anterior
foregut endoderm; VPE, ventral pharyngeal
endoderm; TEP, thymic epithelial progenitors;
TEC, thymic epithelial cells.
(B) Gene expression analysis of day 11 hESCs
treated with the indicated factor combinations
(conditions 1–7) (n = 4–10). Fetal and adult human
thymus samples served as controls. Values are
normalized to TBP, relative to undifferentiated
hESCs, and shown as mean ± SD. Dash lines
correspond to fetal expression levels that were
used as a guide to optimize the differentiation
protocol (*p < 0.05, **p < 0.01, ***p < 0.001,
unpaired Student’s t test, compared to undiffer-
entiated hESCs).
(C) Immunofluorescence analysis of stage 4
cultures differentiated with condition 7 for HOXA3
(green) and EpCAM (red) protein expression.
Nuclei were stained with DAPI. Scale bar = 50 mm.
See also Figure S1.
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using FOXN1 and HOXA3 expression as readouts for thymic
specification.
As summarized in Figure 1A, hESCs were sequentially differ-
entiated into DE, AFE, ventral pharyngeal endoderm (VPE), and
TEPs.We first used a previously describedmethod to induce dif-
ferentiation into DE using activin A (D’Amour et al., 2005). At the
end of stage 1, the majority of the cells coexpressed SOX17 and
FOXA2, confirming efficient specification to DE (Figure S1A
available online). Next, to promote the development of anterior-
ized and ventralized endoderm competent to give rise to
FOXN1+HOXA3+ TEPs, we added activators and inhibitors of
signaling pathways that have been shown to influence anterior-
posterior and ventral-dorsal identities of emerging definitive
endoderm (Zorn and Wells, 2009). We found that treatment of
hESCs with high levels of activin A for 5 days (stage 1), followed
by the addition of BMP4, RA, and the TGFb inhibitor LY364947220 Cell Stem Cell 13, 219–229, August 1, 2013 ª2013 Elsevier Inc.(stage 2 and 3), and then BMP4 and RA
alone (stage 4), led to a significant in-
crease in FOXN1 and HOXA3 expression
over undifferentiated hESCs at the end of
stage 4 (Figure 1B, condition 6). In addi-
tion, hESCs differentiated under these
conditions expressed EYA1 and GCM2,
two markers found in the developing third
pharyngeal pouch (Figure S1B), thus con-
firming the formation of pharyngeal endo-
derm (PE) in our cultures. Interestingly,
HOXA3 and EYA1 expression levels
obtained with these culture conditions
were not as high as those observed with
other treatments (Figures 1B and S1B,
conditions 1–5). These observations sug-
gest that specification to the thymic line-
age occurs more efficiently when thelevels of expression of these key factors remain below a certain
threshold. Importantly, our results also reveal that the duration of
the activin A treatment, as well as the presence of BMP4 and RA
during stages 2–4, are crucial to induce high levels of FOXN1
expression (Figure 1B, conditions 2–6).
Next, to optimize the efficiency of differentiation of AFE to VPE
and TEPs, cells were differentiated up to stage 2 with condition 6
before being exposed to additional molecules involved in
pharyngeal pouch patterning or involved directly in the induction
of Foxn1 expression (Balciunaite et al., 2002; Frank et al., 2002;
Bleul and Boehm, 2005; Moore-Scott andManley, 2005; Gordon
et al., 2010; Neves et al., 2012). We found that the simultaneous
addition of BMP4, RA, Wnt3a, FGF8b, and the Shh inhibitor
cyclopamine at stages 3 and 4 led to an evenmore robust induc-
tion of FOXN1, while maintaining levels of HOXA3 and EYA1
similar to those found in human fetal thymus (Figures 1B and
S1B, condition 7). Immunostaining and flow cytometry analysis
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ber of cells differentiated under these conditions expressed
HOXA3 (13.7% ± 2.8%) and EpCAM (95% ± 2%), an epithelial
marker expressed by many epithelial cells, including TEPs
(Rossi et al., 2006) (Figures 1C and S1C). Taking into account
that the optimized protocol (condition 7) typically generated
1,000,000 cells from a starting population of 1,000,000 undiffer-
entiated hESCs, this method thus yielded approximately 14%
HOXA3+EpCAM+ double-positive output cells. Additional gene
expression analysis for markers of other endoderm derivatives
revealed that, while markers of thyroid (NKX2.1, PAX8), lung
(NKX2.1, FOXP2), parathyroid (PTH), and pancreas (PDX1)
were not expressed, low levels of liver markers (AAT, ALB,
CYP3A4, and CYP3A7) could be detected (Figure S1D), sug-
gesting that some cells were specified to the liver lineage.
Given that FOXN1 is also expressed in skin epithelial cells,
we further tested for the presence of markers of early skin dif-
ferentiation (KRT1 and KRT10). The absence of such markers
(Figure S1D) rules out the possibility that the induction in
FOXN1 expression was due to the generation of ectoderm-
derived skin cells in the cultures. The optimized differentiation
protocol was also tested on HUES4 cells to assess efficiency
in another hESC line. As shown in Figures S1E–S1G, FOXN1
and HOXA3mRNA transcription, as well as HOXA3 and EpCAM
protein expression, were significantly induced. These data indi-
cate that the differentiation protocol can be applied to other
pluripotent stem cell lines. Taken together, these results
demonstrate that efficient commitment of hESCs to the thymic
lineage can be attained by precisely regulating the activities of
TGFb, BMP4, RA, Wnt, Shh, and FGF signaling throughout
differentiation.
hESC-Derived TEPs Mature into TECs In Vivo
Although differentiated cells in our cultures express genes
important for thymic identity such as FOXN1, HOXA3, and
EYA1, marker genes characteristic of mature TECs such as
HLA-DRA (MHC class II molecule) and AIRE were not detected
(data not shown). This was not surprising since interactions of
TEPs with developing T cell progenitors are necessary to stimu-
late maturation into functional TECs (Shores et al., 1994;
Holla¨nder et al., 1995; Klug et al., 2002). To test the capacity of
in vitro generated TEPs to further mature, we transferred them
to an environment where they would be in contact with lymphoid
progenitors. We employed nude mice carrying a mutation in
Foxn1 that prevents the development of a functional thymus
without precluding the formation of a lymphoid progenitor
compartment. hESC-derived TEPswere thus transplanted under
the kidney capsule of nude mice and grafts were analyzed
8–20 weeks later for the expression of genes found in mature
TECs. Nude mice grafted with human fetal thymus (HFT) were
used as positive controls. As shown in Figure 2A, while FOXN1
was expressed at similar levels in grafts when compared to
in vitro differentiated TEPs, a substantial upregulation in the
expression of the differentiated TEC marker genes HLA-DRA,
Delta-like 4 (DLL4), CCL25, CXCL12, and SCF was observed in
TEP grafts, indicating increased maturation of TEPs upon trans-
plantation. Expression of AIRE was not detected in TEP grafts
(data not shown). Immunofluorescence analysis using an anti-
body recognizing a wide spectrum of different cytokeratinsCdemonstrated the presence of epithelial structures in the grafts
(Figure 2B). More importantly, antibodies for cytokeratins
marking mature mTECs (K5) and cTECs (K8) revealed K5+ and
K8+ areas resembling normal thymic architecture in the TEP
grafts, similar to that observed in HFT grafts (Figure 2C). These
results suggest that K5+K8+ TEPs in hESC-derived grafts can
give rise to K5+K8 and K5K8+ TECs in vivo. Taken together,
these data indicate that hESC-derived TEPs acquire char-
acteristics of mature TECs upon transplantation into athymic
nude mice.
hESC-Derived TECs Support the Development of New
T Cells
In addition to providing an appropriate environment for thematu-
ration of TEPs into TECs, this experimental system also allows
for testing of the functionality of transplanted cells. Indeed,
when provided with functional thymic tissue from mouse
(Gordon et al., 2004; Bleul et al., 2006) or human (Kollmann
et al., 1993) origin, the lymphoid progenitors of nude mice can
develop intomature T cells through the typical stepwise progres-
sion of CD4CD8 double-negative (DN), CD4+CD8+ double-
positive (DP), and mature single-positive (SP) CD4+ or CD8+
T cells. To assess the functionality of transplanted TEPs gener-
ated using our method, we monitored the emergence of DP
and SP T cells in the peripheral blood, secondary lymphoid
organs, and grafts. Mice grafted with either hESCs differentiated
with a control protocol (spontaneous hESCs differentiation in the
absence of signaling factors) or HFT served as negative and pos-
itive controls, respectively.
As reported previously, a small number of extrathymically
generated CD4+ and CD8+ SP T cells were detected in the
peripheral blood and spleens of nongrafted and control-grafted
nude mice (Figure 3A and Figure 4A) (Kennedy et al., 1992; Bleul
et al., 2006). However, starting approximately 10 weeks after
transplantation, we observed an increase in the number of
CD4+ and CD8+ SP T cells specifically in the peripheral blood
of TEP and HFT recipient mice (Figure 3A), suggesting that trans-
planted TEPs could support the generation of new T cells.
Consistent with this result, histological analysis of hematoxylin-
eosin (H&E) stained tissue revealed the presence of lymphoid
cells in the grafts (Figure S2A). Immunofluorescence and flow
cytometry analysis of grafts harvested 4–12 weeks (for HFT) or
8–25 weeks (for TEP and control) after transplantation demon-
strated that CD4+CD8+ DP T cells, as well as CD4+ and CD8+
SP T cells, could be detected in TEP and HFT grafts, but not in
control grafts (Figures 3B–3D and S2B–S2C). Although the total
number of T cells isolated from HFT and TEP grafts was lower
than what is normally found in thymopoietic tissue (Figure S2D),
there were no significant differences between the two groups.
These results confirmed that hESC-derived TEPs could indeed
support thymopoiesis upon transplantation into athymic mice.
Notably, similar to what is observed during the progression
fromDP to SP T cells in a normal mouse thymus, the T cell recep-
tor (TCR) complex proteins CD3 and TCRb were properly
expressed on DP and SP T cells from TEP and HFT grafts (Fig-
ure 3E), indicating successful T cell receptor gene rearrange-
ment and positive selection of newly generated T cells. While
we saw clear evidence for canonical T cell maturation, we also
observed variations in the kinetics and extent of thymopoiesisell Stem Cell 13, 219–229, August 1, 2013 ª2013 Elsevier Inc. 221
Figure 2. hESC-Derived TEPs Mature into TECs In Vivo
(A) Gene expression analysis of undifferentiated hESCs (ES, n = 4), hESCs differentiated with condition 7 (TEPs d11, n = 4), and grafts recovered from HFT (n = 5)
and TEP (n = 6) recipient nudemice (8–20 weeks after transplantation). Fetal and adult human thymus samples served as controls. Values are normalized to TBP,
relative to undifferentiated hESCs, and shown as mean ± SD (*p < 0.05, Mann-Whitney test, compared to TEPs d11).
(B and C) Immunofluorescence analysis of HFT and TEP grafts recovered from nude mice (6–8 weeks after transplantation). (B) Epithelial cells within grafts were
identified using a wide spectrum cytokeratin antibody (red). hESC-derived tissue is demarcated from the kidney by white dashed lines. Nuclei were stained with
DAPI. Scale bar = 100 mm. (C) Cytokeratin 8 (K8) (green) and cytokeratin 5 (K5) (red) staining identify cortical and medullary TECs, respectively, while K5+/K8+
double positivity (yellow) indicates progenitor cells. Insets display higher magnification of dashed line areas, showing the three cell types in close proximity. Scale
bar = 50 mm.
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of the same group (Figures 3A–3D and S2A–S2C). A likely expla-
nation comes from the differences in the developmental stage of
TECs in HFT grafts when compared to hESC-derived TEPs, as
well as from variations in engraftment efficiency. Thymopoiesis
was also not sustained over prolonged periods of time as re-
vealed by the progressive decline in the number of DP T cells
in both TEP grafts and HFT grafts (Figure S2B). Since nude
mice possess residual natural killer cell activity and can also
develop autoimmunity in multiple organs following xenogeneic222 Cell Stem Cell 13, 219–229, August 1, 2013 ª2013 Elsevier Inc.transplantation of thymic tissue (Taguchi et al., 1986; Fudaba
et al., 2008), it is possible that the grafts are being damaged
over time, leading to a decrease in thymopoiesis. Immunofluo-
rescence analysis of HFT and TEP grafts for the mitotic marker
Ki67 also showed that, while low levels of proliferating
cytokeratin+ cells could be detected in HFT and TEP grafts (Fig-
ure S2E), most CD3+ T cells were found to be negative for Ki67
(Figure S2F). Taken together, the increase in CD4+ and CD8+
SP T cells in the peripheral blood of TEP-grafted mice combined
with the presence of CD4+CD8+ DP and SP T cells in the grafts
Figure 3. hESC-Derived TECs Support T Cell Development in Athymic Mice
(A) Flow cytometric analysis of cells isolated from peripheral blood of HFT (n = 2–6), TEP (n = 4–10), and control (n = 3–10) nude recipients for the presence of
mouse CD4+ andCD8+ SP T cells. Values are shown asmean ± SD (*p < 0.05, unpaired Student’s t test, compared to control); #, similar to what has been reported
with other xenografts in nude animals (Taguchi et al., 1986; Fudaba et al., 2008); mice graftedwith HFT started showing signs of autoimmunity andwere sacrificed
before 15 weeks.
(B) Immunofluorescence analysis of HFT and TEP grafts recovered from nude mice for the presence of mouse CD8+ (green), CD4+ (red) and CD8+CD4+ DP
(yellow) T cells. hESC-derived tissue is demarcated from the kidney by white dashed lines. Nuclei were stained with DAPI. Scale bar = 50 mm.
(C–E) Flow cytometric analysis of cells recovered from WT mouse thymus, HFT, TEP, and control grafts for the presence of mouse CD4+ (red), CD8+ (blue) and
CD4+CD8+ DP (green) T cells. (C) Representative plots from WT mouse thymus and grafts harvested 9 weeks (HFT) or 15 weeks (TEP and control) after
transplantation. (D) Quantification of the percentage of mouse DP T cells in WTmouse thymus (n = 5), HFT (n = 5), TEP (n = 6), and control (n = 6) grafts harvested
4–12 weeks (HFT) or 8–22 weeks (TEP and control) after transplantation (*p < 0.05, **p < 0.01, Mann-Whitney test). (E) Cell surface expression of mouse T cell
markers CD3 and TCRb on DP T cells (green), CD4+ SP T cells (red), and CD8+ SP T cells (blue).
See also Figure S2.
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development of new T cells.
T Cells Generated in TEP-Recipient Nude Mice Are
Functional
In addition to the T cells detected in the grafts, we also found
evidence of migration of functional T cells to the peripheral im-
mune system in TEP-grafted mice. As shown in Figures 4A and
4B, a significant increase in CD4+ and CD8+ SP T cell popula-
tions, and more prominently, in TCRb+CD4+ and TCRb+CD8+
T cells, could be detected in the spleen of HFT and TEP-
grafted mice over nongrafted and control-grafted mice. Impor-
tantly, we also observed positive selection of CD4+Foxp3+Cregulatory T cells (Tregs), a subset of lymphocytes essential
for establishing immune tolerance through suppression of
autoreactive T cells (Sakaguchi, 2000). In HFT and TEP-grafted
mice, 4.6% ± 1.8% and 2.9% ± 0.8% of total CD4+ cells were
positive for Foxp3, whereas only 0.4% ± 0.3% and 0.2% ±
0.1% were positive in control and nongrafted mice, respec-
tively (Figure 4C). Thus, not only did we observe increased
formation of T cells, hESC-derived TEPs also promoted forma-
tion of T cell subsets otherwise almost completely absent in
control animals.
Furthermore, spectratype analysis of the TCR repertoire
of cells recovered from nude recipient mice indicated more
diverse TCR Vb rearrangements in HFT and TEP recipients inell Stem Cell 13, 219–229, August 1, 2013 ª2013 Elsevier Inc. 223
Figure 4. New T Cells Are Generated in
TEP-Recipient Nude Mice
(A–C) Splenocytes recovered from WT (n = 4),
HFT-grafted (n = 8), TEP-grafted (n = 4), control-
grafted (n = 7), and nongrafted (n = 5) nude mice
were analyzed by flow cytometry for mouse CD4,
CD8, TCRb, and Foxp3 expression. (A) Percentage
of CD4+ (red) and CD8+ (blue) splenocytes. (B)
Percentage of CD4+TCRb+ (red) and CD8+TCRb+
(blue) splenocytes. (C) Percentage of Foxp3+ reg-
ulatory T cells (purple) among CD4+ SP T cells.
(p* < 0.05, p** < 0.01, unpaired Student’s t test,
compared to control.)
(D and E) Assessment of TCR repertoire diversity
by spectratype analysis of the CDR3 Vb regions
of mouse T cells recovered from spleens of WT
(n = 3), HFT (n = 4), TEP (n = 4), and control (n = 5)
recipient nude mice. (D) Representative spec-
tratypes from three Vb families are shown. (E)
Spectratype complexity score representing the
sum of peaks from each of the 24 Vb family tested.
(p* < 0.05, p** < 0.01, ***p < 0.001, unpaired
Student’s t test.)
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that hESC-derived TECs can support the development of T cells
with a diverse TCR repertoire. Another critical test for T cell func-
tion is their ability to proliferate upon TCR stimulation. Labeling of
cells with carboxyfluorescein diacetate succinimidyl ester
(CFSE) followed by stimulation with anti-CD3/CD28 antibodies
revealed that 74% ± 6% of CD4+ and 84% ± 6% of CD8+
T cells isolated from HFT-grafted mice and 47% ± 3% of CD4+
and 68% ± 5% of CD8+ T cells isolated from TEP-grafted mice
proliferated following TCR stimulation (Figure 5A). These results224 Cell Stem Cell 13, 219–229, August 1, 2013 ª2013 Elsevier Inc.indicate that a significant portion of newly
formed T cells is functional and respon-
sive to activation signals through the
TCR. Relative to wild-type (WT) mice,
lower TCR diversity and lower levels of
TCR stimulation-induced proliferation
were seen in HFT- and TEP-grafted
mice (Figure 4E and Figure 5A), consis-
tent with cross-species differences that
likely impair full activation/differentiation
of murine T cells upon interaction with
human TECs (Taguchi et al., 1986; Koll-
mann et al., 1993; Fudaba et al., 2008).
In addition, significant proliferation of
T cells from HFT-grafted mice and CD8+
T cells from TEP-grafted mice was ob-
served in response to allogeneic stimu-
lator cells (Figure 5B), indicating that
T cells are capable of allogeneic re-
sponses. CD4+ T cells from HFT-grafted
mice and CD8+ T cells from TEP-grafted
mice also proliferated in response to stim-
ulator cells from nu/+ mice (Figure 5C).
This result supports the idea that T cells
in HFT- and TEP-grafted mice have
been selected on human MHC and arethus responding to MHC-mismatched stimulator cells. As an
additional measure of functionality, we evaluated the ability of
grafted mice to reject allogeneic skin transplants. As shown in
Figure 6, we observed increased graft rejection in HFT (median
survival time or MST = 20.5 days) and TEP (MST = 19.5 days)
recipient nude mice when compared with control mice (MST >
35 days), confirming that the T cells generated in HFT- and
TEP-grafted mice are functional in vivo. Summarily, these data
demonstrate the ability of transplanted TEPs to support the gen-
eration of new functional T cells in athymic nude mice.
Figure 5. T Cells Generated in TEP-Recipient Nude Mice Respond To TCR and Allogeneic Stimulation In Vitro
(A) Proliferation of splenic T cells following in vitro TCR stimulation. Splenocytes fromWTC57BL/6 (n = 4), HFT (n = 5), TEP (n = 4), and control (n = 6) recipient nude
mice were labeled with CFSE and cultured for 3 days in the presence of anti-CD3/CD28. Cells were stained for CD4 and CD8 and gated populations were
analyzed by flow cytometry for CFSE levels. Nonstimulated cells are represented by shaded histograms. (*p < 0.05, **p < 0.01, ***p < 0.001, unpaired Student’s t
test, compared to control.)
(B andC) Proliferation of enriched T cells in response toCD11c+ APCs. Enriched T cells fromWTC57BL/6 (n = 6–8), HFT (n = 8–10), TEP (n = 8–12), and control (n =
4–8) recipient nude mice were labeled with CFSE and cultured for 4 days in the presence of CD11c+ APCs isolated from NOD (B) or nu/+ mice (C). Cells were
stained for CD90.2, CD4, and CD8, and gated populations were analyzed by flow cytometry for CFSE levels. Nonstimulated cells are represented by shaded
histograms. (*p < 0.05, unpaired Student’s t test, compared to control.)
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Figure 6. T Cells Generated in TEP-Recipient Nude Mice Mediate
In Vivo Immune Responses
(A) Survival of allogeneic skin grafts (from C57BL/6 mice) in nu/+ (n = 4), HFT
(n = 4), TEP (n = 6), and control (n = 9) recipient nude mice.
(B) Representative images of allogeneic skin grafts in nu/+, HFT, TEP, and
control recipient nude mice at the time of rejection.
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Although many cell lineages generated from human pluripotent
stem cells express appropriate marker genes, very few have
been shown to give rise to fully differentiated functional cells.
In this study, we present a method to differentiate hESCs into
TEPs that mature into functional TECs when transplanted in vivo
(Figure 7). Our study demonstrates that the success of coaxing
hESCs into functional TEPs depends on the accurate in vitro
recapitulation of in vivo embryonic signaling events, including
early specification of anterior-posterior and dorsal-ventral cell
identities that are permissive for complete thymus development.
Although it has been reported previously that anteriorization of
DE can be achieved by blocking TGFb signaling either alone
(Mou et al., 2012) or in conjugation with BMP inhibition (Green
et al., 2011; Longmire et al., 2012), we show that activation of
RA signaling is also required for accurate anterior-posterior
patterning of the foregut prior to thymic specification. Indeed,
expression of the transcription factor HOXA3, a member of the
Hox family that specifies positional identity along the anterior-
posterior axis in the developing embryo, was not induced in
the absence of RA. Consistent with previous studies showing
that Hoxa3 is essential for thymic specification in vivo (Manley
and Capecchi, 1995), our results strongly suggest that in vitro
specification of hESCs to the thymic lineage also requires culture
conditions that induce appropriate levels of expression of this
transcription factor. Even though significant induction of
FOXN1 expression was observed with this method, the levels
of expression were lower than what is found in control thymic
tissue. This is most likely due to the generation of heterogeneous
cultures, as suggested by the quantification of HOXA3+EpCAM+
cells, which represent approximately 14% of the cells. Future226 Cell Stem Cell 13, 219–229, August 1, 2013 ª2013 Elsevier Inc.studies will focus on defining conditions that enhance efficiency
of differentiation to the thymic lineage as well as improving the
purity of the cells by isolating them using cell surface markers
yet to be identified.
Importantly, our data reveal that transplantation of in-vitro-
generated TEPs in athymic mice leads to the upregulation of
multiple genes critical for TEC function. Indeed, hESC-derived
TECs expressed the chemokines/cytokines CCL25, CXCL12,
and SCF, which are normally produced by TECs to attract
hematopoietic progenitors to the thymus and promote lymphoid
progenitor development (Caldero´n and Boehm, 2012). In addi-
tion, hESC-derived TECs expressed Delta-like 4 (DLL4), a Notch
ligand that induces the commitment of hematopoietic progeni-
tors to the T cell lineage. The presence of this crucial molecule
combined with the appropriate chemotactic cues thus most
likely helped promote the homing and development of DP
T cell progenitors in TEP grafts.
Furthermore, once T cell progenitors present in the thymus
have rearranged the TCR gene and successfully progressed to
the DP stage, their survival as well as their commitment to the
CD4+ or CD8+ lineages depends on interaction with MHC-self-
peptide complexes displayed on TECs. In addition to MHC class
I molecules, which are expressed ubiquitously on most cells, the
upregulation of MHC class II molecules by TEPs was likely to be
critical for their ability to support positive selection of developing
CD4+ T cells. The capacity of hESC-derived TECs to success-
fully regulate the transition of DP to SP T cells was confirmed
by the presence of an increased number of diverse and respon-
sive SP T cells in the peripheral blood and spleen of TEP-grafted
mice. However, even though a significant amount of CD4+ SP
T cells were generated in TEP-grafted mice, the efficiency was
reduced when compared to HFT grafts, most likely due to lower
MHC class II expression in hESC-derived TECs.
Importantly, T cells from TEP-grafted mice were responsive to
direct TCR activation and stimulation by allogeneic antigen-pre-
senting cells (APCs) in vitro. They could also mediate rejection of
allogeneic skin grafts in vivo, further confirming their function-
ality. However, the response to allogeneic stimulator cells of
CD4+ T cells from TEP-grafted mice was lower than what was
observed in WT and HFT mice, suggesting that this subset of
T cells was not able to mount efficient responses against alloan-
tigens. Further studies will be required to address this issue in
more detail. Interestingly, TECs also promoted the generation
of Tregs, a subset of T cells that are crucial for the maintenance
of immune tolerance through the inhibition of self-reactive T cells
in the periphery. Our data thus clearly demonstrate that hESC-
derived TEPs transplanted in athymic mice acquire characteris-
tics of mature TECs that allow them to support multistage T cell
development.
The ability to generate functional thymic epithelium from
human pluripotent stem cells will have numerous applications,
including enabling modeling of human immune diseases using
patient-specific induced pluripotent stem cell (iPSC) lines. It
will alsomake possible the use of stem cells as a potential source
of TECs to enhance or restore thymic function. Importantly, since
the thymus has the unique capacity to modify tolerance in an
antigen-specific manner, transplantation of TEPs has the poten-
tial to promote graft-specific immune tolerance without the need
for sustained immunosuppression (Nobori et al., 2006). By
Figure 7. Model for the Generation and
Maturation of hESC-Derived TEPs in
Thymus-Deficient Nude Mice
(1) TEPs are generated from hESCs in vitro using
the indicated combination of factors. (2) At the end
of stage 4, TEPs are transplanted under the kidney
capsule of thymus-deficient nude mice, which
allows the in vivo maturation of TEPs into TECs. (3)
In the presence of hESC-derived TECs, mouse
T cell progenitors from the host can mature from
CD4CD8 DN T cells (white) to CD4+CD8+ DP
(green) and SP T cells (blue and red). (4) Functional
T cells migrate to the periphery of TEP-grafted
mice where they can mediate immune responses
such as rejection of allogeneic skin grafts.
Cell Stem Cell
Generation of Functional TECs from hESCsallowing the generation of a T cell repertoire tolerant to stem cell
self antigens, cotransplantation of stem-cell-derived TECs could
prevent immune rejection of other transplants derived from the
same cell line, potentially having a major impact on the effective-
ness of stem-cell-based therapies. This may be a particularly
attractive approach in autoimmune disease settings such as
type 1 diabetes, where both b cell replacement and immunomo-
dulation are likely required for a successful outcome.
EXPERIMENTAL PROCEDURES
Cell Culture
Undifferentiated CyT49 and HUES4 hESCs were maintained on mitomycin-C-
treated mouse embryonic fibroblast (MEF) feeders (Millipore) as previously
described (D’Amour et al., 2006). For differentiation, hESCs were plated on
MEFs at a density of 6.25 3 104 cells/cm2 and differentiated 72 hr later as
follows: stage 1 and 2 of differentiations were carried out in RPMI 1640 media
(Invitrogen) supplementedwith increasing concentrations of KSR (0%on day 1
[d1], 0.2% on d2–3, and 2% on d4) or B27 (0.5% on d5–7). For stages 3 and 4,
cells were differentiated in DMEM/F12 with 0.5% B27. The following factorsCell Stem Cell 13, 219–22were added: activin A, 100 ng/ml (d1–5); Wnt3a,
25 ng/ml (d1) or 50 ng/ml (d8–11); all-trans retinoic
acid (RA), 0.25 mM (d4–7) or 0.1 mM (d8–11); BMP4,
50 ng/ml (d6–11); LY364947, 5 mM (d6–9); FGF8b,
50 ng/ml (d8–11); and KAAD-cyclopamine, 0.5 mM
(d8–11). Supplements and factors were from
Invitrogen (B27, KSR), R&D Systems (activin A,
Wnt3a, BMP4, and FGF8b), Sigma (RA), and
Millipore (KAAD-cyclopamine, LY364947).
Real-Time Quantitative PCR
RNA extraction and real-time quantitative PCR
from hESC cultures and dissected grafts was
performed as described in the Supplemental
Information.
Immunofluorescence
hESC cultures were fixed and immunostained
according to the protocol described in the Supple-
mental Information. For tissue sections, kidneys
were embedded in OCT medium (Tissue-Tek)
and were processed as described in the Supple-
mental Information.
Kidney Capsule Implantations
hESC cultures differentiated using condition 1
(control) or 7 (TEP) were either incubated with
Accutase for 5 min or cut into 2–5 mm squares
using a needle. Cell clumps were lifted with a cell scraper, collected by centri-
fugation, washed, and resuspended in differentiation media +10 mg/ml DNase I
(Sigma). Following a 4–6 hr incubation at 37C, 2–4 3 106 cells were im-
planted under the kidney capsule of nude mice as described (Russ and Efrat,
2011). HFT grafts were generated by implanting a1 mm3 piece of HFT under
the kidney capsule of nude mice using a similar technique. Fresh HFT was
obtained from Advanced Bioscience Resources. Four to twenty-five weeks
after transplantation, kidneys were surgically extracted and the tissue was
processed for histology, RNA extraction, or analysis by flow cytometry.
Flow Cytometry
Lymphocytes isolated by mashing thymi, dissected grafts, or spleens on a
40 mm cell-strainer were processed as described in the Supplemental
Information.
Spectratyping
Total RNA was isolated from 5–10 3 106 splenocytes using TRIzol reagent
(Invitrogen) and RNeasyMini columns (QIAGEN) followed by reverse transcrip-
tion into cDNA using SuperScript III first-strand synthesis system (Invitrogen).
PCR and run-off reactions were performed using a common Cb primer and
primers specific for each TCR Vb family as described previously (Currier and9, August 1, 2013 ª2013 Elsevier Inc. 227
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Generation of Functional TECs from hESCsRobinson, 2001). Labeled products from the run-off reactions were analyzed
using a 3130xl Genetic Analyzer (Applied Biosystems) and GeneMapper soft-
ware (Applied Biosystems). The overall spectratype complexity score was
determined as described in the Supplemental Information.
Proliferation Assay
Splenocytes (107) were labeled with a solution of 5 mm CFSE diluted in
DMEM+2% FBS for 5 min at RT. An equal volume of FBS was added and
cells were washed with DMEM+2% FBS. CFSE-labeled cells were then
cultured in round-bottom 96-well plates precoated with anti-CD3 and
anti-CD28 antibodies (10 mg/ml) at a cell density of 4 3 105 cells/well.
After 3 days, loss of CFSE in CD4+ and CD8+ T cells was assayed by
staining with anti-CD4 and anti-CD8 antibodies and analyzing by flow
cytometry.
Mixed Lymphocyte Reaction
T cells and APCswere prepared as described in the Supplemental Information.
CFSE-labeled T cells were added to round-bottom 96-well plates at 2 3 105
cells per well in complete DMEM media. Enriched dendritic cells were added
to wells at 23 104 cells per well. After 4 days of culture, loss of CFSE in CD4+
and CD8+ T cells was assayed by staining with anti-CD90.2, anti-CD4, and
anti-CD8 antibodies and analyzing by flow cytometry.
Skin Grafting
Ear skin from an allogeneic C57BL/6 donor mouse was placed on graft beds of
approximately 8 mm2 on the flanks of anesthetized recipient mice. Grafts were
covered with Vaseline gauze and fixed with fabric strips. Bandages were
removed 7 days later, and grafts were monitored every other day for signs of
rejection. Grafts were considered rejected when >80% of the graft area was
necrotic.
Mice
NU/J mice were obtained from Jackson Laboratories. Mice used in this study
were maintained according to protocols approved by the UCSF Institutional
Care and Use of Animals Committee (IACUC).
Statistics
Data was analyzed with GraphPad Prism software using an unpaired
two-tailed Student’s t test or a Mann-Whitney test. Error bars in bar diagrams
represent standard deviation of the samples.
SUPPLEMENTAL INFORMATION
Supplemental Information for this article includes Supplemental Experimental
Procedures and two figures and can be found with this article online at http://
dx.doi.org/10.1016/j.stem.2013.04.004.
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